Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Universal Detection Technology was a biodefense company specializing in the development of automated systems for the detection of biological, chemical, and radiological threats. The company's flagship technology, the Biological Warning System (BWA), was designed to provide continuous, real-time monitoring of air for pathogens such as anthrax and ricin. UDT's products were marketed to government agencies, first responders, and commercial building managers to mitigate the risks of bioterrorism. Despite its early prominence in the biosecurity sector following the 2001 anthrax attacks, the company has since become inactive and no longer maintains active operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Universal Detection Technology.